Home › Hidradenitis Suppurativa › North Carolina
Hidradenitis Suppurativa clinical trials in North Carolina
5 studies for Hidradenitis Suppurativa are looking for participants at sites in North Carolina.
Cities in North Carolina
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
- OnSite Clinical Solutions LLC, Huntersville
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT07665437ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
- Oruka Therapeutics Investigative Site, Chapel Hill
RecruitingPhase 2
Ages 18 to 79 · All sexes · Updated Sep 24, 2026 · NCT07783542A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 106, Chapel Hill
- Up0122 102, Durham
RecruitingPhase 1
Ages 18 and older · Women · Updated Sep 18, 2026 · NCT06888193Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US031, Chapel Hill
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06855498A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Duke University, Durham
RecruitingObservational study
Ages 18 to 71 · All sexes · Updated Apr 16, 2026 · NCT07123038From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.